This project identifies and studies two competition-law & -policy areas of issues in the pharmaceutical market in Australia: a lack of competition law cases and unnecessary barriers to entering the specific pharmaceutical markets.

Pharmaceuticals, most notably patented pharmaceuticals, are more expensive in Australia than in other developed countries. One of the reasons is that the current law and policy tend to favour and overprotect patented drugs over the generics. This potential overprotection of patented drugs can lead to a lack of competition to the detriment of consumers and the Australian economy.

Project members

Dr Barbora Jedlickova

TC Beirne School of Law